Owner Janssen Pharmaceutica NV

Inventors Decorte, Bart L.; Desjarlais, Renee L.; Huang, Yifang; Parker, Michael H.; Hlasta, Dennis J.

Agent Shelston IP

Pub. Number AU-A-2011224417

PCT Pub. Number WO2011/112685

Priority 61/312,301 10.03.10 US

Filing date 9 March 2011

Wipo publication date 15 September 2011

C07D 211/66 Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

A61K 31/4375

A61K 31/4436

A61K 31/4439

A61K 31/444

A61P 19/02 Drugs for skeletal disorders

C07D 401/06 Heterocyclic compounds containing two or more hetero rings

C07D 407/06 Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group

C07D 407/14 Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group

C07D 409/06 Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 409/14 Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 417/06 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07D 417/14 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group